Friulchem SpA
MIL:FCM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AU Small Finance Bank Ltd
BSE:540611
|
IN |
|
Sinops Inc
TSE:4428
|
JP |
|
DMW Corp
TSE:6365
|
JP |
|
T
|
Transmit Entertainment Ltd
HKEX:1326
|
HK |
Friulchem SpA
Total Current Liabilities
Friulchem SpA
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Friulchem SpA
MIL:FCM
|
Total Current Liabilities
€17.5m
|
CAGR 3-Years
46%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Newron Pharmaceuticals SpA
SIX:NWRN
|
Total Current Liabilities
€50.1m
|
CAGR 3-Years
115%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
Total Current Liabilities
€1.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Friulchem SpA
Glance View
Friulchem SpA engages in the research and development of pharmaceutical products for third party contract development and manufacturing organizations. The company is headquartered in Vivaro, Pordenone and currently employs 37 full-time employees. The company went IPO on 2019-07-25.
See Also
What is Friulchem SpA's Total Current Liabilities?
Total Current Liabilities
17.5m
EUR
Based on the financial report for Dec 31, 2023, Friulchem SpA's Total Current Liabilities amounts to 17.5m EUR.
What is Friulchem SpA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
37%
Over the last year, the Total Current Liabilities growth was -1%. The average annual Total Current Liabilities growth rates for Friulchem SpA have been 46% over the past three years , 37% over the past five years .
